Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington’s disease: a 12-month longitudinal study

Overview of attention for article published in Translational Neurodegeneration, July 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Substituted alpha-ethyl phenylalkylamines

Grant US-12465578-B2

United States of America

11 Nov 2025

Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their…

Grant US-12263155-B2

United States of America

01 Apr 2025

Asymmetric allyl tryptamines

Grant US-12239632-B2

United States of America

04 Mar 2025

Use of deuterated empathogens as therapeutic agents

Grant US-12221428-B2

United States of America

11 Feb 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.